
Organ Preservation Market by Preservation Solution (Celsior Solution, Custodial HTK, IGL-1 Solution), Organ Type (Heart, Kidneys, Liver), Technique, End-User - Global Forecast 2024-2030
Description
Organ Preservation Market by Preservation Solution (Celsior Solution, Custodial HTK, IGL-1 Solution), Organ Type (Heart, Kidneys, Liver), Technique, End-User - Global Forecast 2024-2030
The Organ Preservation Market size was estimated at USD 503.93 million in 2023 and expected to reach USD 541.48 million in 2024, at a CAGR 7.72% to reach USD 848.57 million by 2030.
Global Organ Preservation MarketOrgan preservation is an important step in the transplant process to maintain the organ and tissue functional state during organ transplantation. Organ preservation is based on the effects of cooling and hypothermic machine perfusion (HMP) methods to slow biological deterioration in organs removed from their normal physiological environment to match the most suitable recipient patient through organ exchange. The rising instances of organ failure, increasing organ transplantation surgeries, and rising awareness of organ donation activities create a need for organ preservation solutions worldwide. However, the high cost of organ cryopreservation activity and the increasing availability of artificial organs may limit the adoption of organ preservation solutions. Moreover, ongoing technological advancements in research and development of organ cryopreservation are revolutionizing the market. Continuous extension of clinical service offerings and encouragement for organ donation activities by government and NGOs are expected to boost the adoption of organ preservation solutions.
Regional Insights
Organ preservation is growing in the Americas as organ transplantations are increasing due to increased donor matching and improvements in immunosuppressive drugs. The advanced organ preservation methods allow more flexibility in transporting organs of all types to broader geographic locations to address the current critical organ shortage in America. In the European region, organ preservation and transplantation are managed in conformity with the Council of Europe's binding laws and compliant with relevant EU rules. The rising consent for organ donation activities across European countries is increasing market demand for organ preservation solutions. The ongoing research and development of innovative technologies in organ transplants are expected to create lucrative opportunities in organ preservation solutions in the Asia-Pacific region. The relatively low cost of organ transplantation surgeries in countries such as India and China has boosted the region's demand for organ preservation solutions.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Organ Preservation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Preservation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Organ Preservation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, Artivion, Inc., AVIONORD S.R.L., BioLife Solutions Inc., Bridge to Life Ltd., CARDIOLINK S.L., Carnamedica, Dr. Franz Köhler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Essential Pharmaceuticals, LLC by Accord Healthcare Limited, Global Transplant Solutions, Inc., Hemarina SA, Institut Georges Lopez, Lifeline Scientific, Inc., Organ Preservation Solutions Ltd., OrganOx Limited, Paragonix Technologies, Inc., Preservation Solutions, Inc., S.A.L.F. S.p.A., Sandor Medicaids Pvt. Ltd., SAS Advanced Life Solutions, ScubaTx Limited, TransMedics, Inc., TX Innovations B.V., Vascular Perfusion Solutions, Inc., and XVIVO AB.
Market Segmentation & Coverage
This research report categorizes the Organ Preservation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Preservation Solution
Celsior Solution
Custodial HTK
IGL-1 Solution
Perfadex
University of Wisconsin (UW)
Organ Type
Heart
Kidneys
Liver
Lung
Technique
Controlled Oxygenated Rewarming
Ex vivo Machine Perfusion
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Static Cold Storage
End-User
Hospitals
Organ Transplant Centers
Specialty Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Organ Preservation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Preservation Market?
3. What are the technology trends and regulatory frameworks in the Organ Preservation Market?
4. What is the market share of the leading vendors in the Organ Preservation Market?
5. Which modes and strategic moves are suitable for entering the Organ Preservation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
198 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Organ Preservation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising number of organ transplantation surgeries and instances of the multi-organ failure
- 5.1.1.2. Growing demand for preserving solutions for immediate availability of the organ
- 5.1.1.3. Constant increase in the awareness of organ donation
- 5.1.2. Restraints
- 5.1.2.1. Limited awareness and affordaboility constraints of organ preservation techniques
- 5.1.3. Opportunities
- 5.1.3.1. Rapid growth in the R&D for improved organ preservation methods and solutions
- 5.1.3.2. Ongoing extension of clinical service offerings and inventory expansion
- 5.1.4. Challenges
- 5.1.4.1. Availability of the artificial organs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Organ Preservation Market, by Preservation Solution
- 6.1. Introduction
- 6.2. Celsior Solution
- 6.3. Custodial HTK
- 6.4. IGL-1 Solution
- 6.5. Perfadex
- 6.6. University of Wisconsin (UW)
- 7. Organ Preservation Market, by Organ Type
- 7.1. Introduction
- 7.2. Heart
- 7.3. Kidneys
- 7.4. Liver
- 7.5. Lung
- 8. Organ Preservation Market, by Technique
- 8.1. Introduction
- 8.2. Controlled Oxygenated Rewarming
- 8.3. Ex vivo Machine Perfusion
- 8.4. Hypothermic Machine Perfusion
- 8.5. Normothermic Machine Perfusion
- 8.6. Static Cold Storage
- 9. Organ Preservation Market, by End-User
- 9.1. Introduction
- 9.2. Hospitals
- 9.3. Organ Transplant Centers
- 9.4. Specialty Clinics
- 10. Americas Organ Preservation Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Organ Preservation Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Organ Preservation Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Agreement, Collaboration, & Partnership
- 13.3.1.1. HRSA Announces Organ Procurement and Transplantation Network Modernization Initiative
- 13.3.1.2. OrganOx announces partnership with Ochre Bio
- 13.3.2. New Product Launch & Enhancement
- 13.3.2.1. Paragonix Launches Comprehensive Digital Platform for Real-Time Tracking of Donor Organs Destined for Transplantation
- 13.3.2.2. NHS Blood and Transplant launches pound 20 million research units
- 13.3.3. Investment & Funding
- 13.3.3.1. Paragonix Technologies Raises USD 24M in Series B Led by Signet Healthcare Partners
- 13.3.4. Award, Recognition, & Expansion
- 13.3.4.1. The biotechnology company HEMARINA obtains the CE mark for its HEMO2life technology
- 13.3.4.2. Breakthrough device designation granted Lifecradle organ preservation system
- 13.3.4.3. TransMedics Receives FDA PMA Approval of OCS DCD Heart Indication
- 13.3.4.4. FDA approves novel organ preservation device developed across Biomedical Engineering and Surgery
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. 21st Century Medicine
- 14.1.2. Artivion, Inc.
- 14.1.3. AVIONORD S.R.L.
- 14.1.4. BioLife Solutions Inc.
- 14.1.5. Bridge to Life Ltd.
- 14.1.6. CARDIOLINK S.L.
- 14.1.7. Carnamedica
- 14.1.8. Dr. Franz Köhler Chemie GmbH
- 14.1.9. EBERS MEDICAL TECHNOLOGY SL
- 14.1.10. Essential Pharmaceuticals, LLC by Accord Healthcare Limited
- 14.1.11. Global Transplant Solutions, Inc.
- 14.1.12. Hemarina SA
- 14.1.13. Institut Georges Lopez
- 14.1.14. Lifeline Scientific, Inc.
- 14.1.15. Organ Preservation Solutions Ltd.
- 14.1.16. OrganOx Limited
- 14.1.17. Paragonix Technologies, Inc.
- 14.1.18. Preservation Solutions, Inc.
- 14.1.19. S.A.L.F. S.p.A.
- 14.1.20. Sandor Medicaids Pvt. Ltd.
- 14.1.21. SAS Advanced Life Solutions
- 14.1.22. ScubaTx Limited
- 14.1.23. TransMedics, Inc.
- 14.1.24. TX Innovations B.V.
- 14.1.25. Vascular Perfusion Solutions, Inc.
- 14.1.26. XVIVO AB
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ORGAN PRESERVATION MARKET RESEARCH PROCESS
- FIGURE 2. ORGAN PRESERVATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. ORGAN PRESERVATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ORGAN PRESERVATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ORGAN PRESERVATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ORGAN PRESERVATION MARKET DYNAMICS
- FIGURE 7. ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2023 VS 2030 (%)
- FIGURE 8. ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
- FIGURE 10. ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
- FIGURE 12. ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ORGAN PRESERVATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ORGAN PRESERVATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.